[
  {
    "ts": null,
    "headline": "Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth",
    "summary": "Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic partnerships positioning it as a 2025 Buy.",
    "url": "https://finnhub.io/api/news?id=4ae28630494687c056f1f1d8d1efc96c72e398f9bc47178cceda8fb21a5f48dd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742577389,
      "headline": "Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth",
      "id": 133310796,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1462296278/image_1462296278.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic partnerships positioning it as a 2025 Buy.",
      "url": "https://finnhub.io/api/news?id=4ae28630494687c056f1f1d8d1efc96c72e398f9bc47178cceda8fb21a5f48dd"
    }
  },
  {
    "ts": null,
    "headline": "Why Amgen (AMGN) is a Top Value Stock for the Long-Term",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=bc435f61aa10924497a04aa8d0ce921ea1e220bcada936410269884c86e02c80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742566206,
      "headline": "Why Amgen (AMGN) is a Top Value Stock for the Long-Term",
      "id": 133325057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=bc435f61aa10924497a04aa8d0ce921ea1e220bcada936410269884c86e02c80"
    }
  },
  {
    "ts": null,
    "headline": "3 of Goldman Sachs' best investing tips for currently volatile markets",
    "summary": "Volatile times in markets require precision, Goldman Sachs reminds investors.",
    "url": "https://finnhub.io/api/news?id=53de6c4e268d53424f20d6ebfaf8653bf2f6cec39368f385d4a1f70b569e3b67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742563852,
      "headline": "3 of Goldman Sachs' best investing tips for currently volatile markets",
      "id": 133311382,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Volatile times in markets require precision, Goldman Sachs reminds investors.",
      "url": "https://finnhub.io/api/news?id=53de6c4e268d53424f20d6ebfaf8653bf2f6cec39368f385d4a1f70b569e3b67"
    }
  },
  {
    "ts": null,
    "headline": "Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy",
    "summary": "Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects for long-term investment.",
    "url": "https://finnhub.io/api/news?id=2012cfbaa433b0233c82b4e2650cde3928bdf1857ae5c68c2d115d433190debb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742541707,
      "headline": "Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy",
      "id": 133297533,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1444529209/image_1444529209.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects for long-term investment.",
      "url": "https://finnhub.io/api/news?id=2012cfbaa433b0233c82b4e2650cde3928bdf1857ae5c68c2d115d433190debb"
    }
  }
]